For investors worried that the runaway artificial-intelligence trade might be about to hit the skids, prediction markets are already starting to reflect that anxiety.
A daily pill to keep breast cancer away?
Swiss drugmaker Roche is betting on a new frontier drug after losing its lead in the booming cancer treatment market, explains Sarah Muller. (Source: Bloomberg)
Trick or treat? Musk has a long record of saying things have little relation to reality.
JPMorgan Chase & Co.’s securities unit in Turkey said it planned to cease operating in the country.
A decade ago, Elon Musk saw little reason for SpaceX and Tesla Inc. to merge, saying that the ties between the two firms were “really quite tenuous.” Fast forward to 2026 and he’s now openly endorsing the idea, believing “there’s a lot of merit to combining the companies.”
Investors are for sure facing “bubbles,” but Ken Griffin isn’t telling investors to dump those stocks.
Jonathan Ferro, Lisa Abramowicz and Annmarie Hordern speak daily with leaders and decision makers from Wall Street to Washington and beyond. No other program better positions investors and executives for the trading day than “Bloomberg Surveillance.” (Source: Bloomberg)
President Trump praised the UK’s decision to approve the highly controversial Jackdaw gas field.
Jess Shankleman explains why Britain is once again turning to the North Sea. (Source: Bloomberg)
The yield on benchmark French debt hit 5% for the first time since 2002 as rising energy prices exacerbated concern over the country’s fiscal outlook. Alice Gledhill has more on “Bloomberg Open Interest.” (Source: Bloomberg)
“I never paid rent, although I put about $45,000 toward a new kitchen and a roof.”
